Bryan C. Hanson

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Warsaw, IN
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/Megan Bombick, attorney-in-fact for Bryan C. Hanson
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Bryan C. Hanson

Form 4 holding Group Pres & CEO Health Care

3M CO

Security class
Restricted Stock Units
Shares / value
126,754
Estimated value
$12,656,387
Report date
01 Sep 2023
Price
$99.85
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

ZIMMER BIOMET HOLDINGS, INC.

Security class
Common Stock
Shares / value
102,797
Estimated value
$10,767,986
Report date
21 Feb 2023
Price
$104.75
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

Solventum Corp

Security class
Common Stock
Shares / value
144,722
Estimated value
$9,450,346
Report date
13 May 2026
Price
$65.30
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

Solventum Corp

Security class
Restricted Stock Units
Shares / value
34,316
Estimated value
$7,089,245
Report date
13 May 2026
Price
$74.06
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

ZIMMER BIOMET HOLDINGS, INC.

Security class
Restricted Stock Units
Shares / value
47,625
Estimated value
$4,988,719
Report date
06 Mar 2023
Price
$104.75
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Bryan C. Hanson

4 MMM

3M CO

Report period
01 Sep 2023
Transactions
1
Transaction value
$0
Accepted by SEC
06 Sep 2023, 10:55
Role
Group Pres & CEO Health Care
Next action
Open filing details
3 MMM

3M CO

Report period
01 Sep 2023
Transactions
0
Transaction value
$0
Accepted by SEC
06 Sep 2023, 10:41
Role
Group Pres & CEO Health Care
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .